Citations for Computational neuropharmacology of CA1 pyramidal neuron (Ferrante et al. 2008)

Legends: Link to a Model Reference cited by multiple papers

Ferrante M, Blackwell KT, Migliore M, Ascoli GA (2008) Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets. Curr Med Chem 15:2456-71 [PubMed]

References and models cited by this paper

References and models that cite this paper

http, ()
(2004) Safinamide: FCE 26743, NW 1015, PNU 151774, PNU 151774E. Drugs R D 5:355-8 [Journal] [PubMed]
Abbott LF, Farhi E, Gutmann S (1991) The path integral for dendritic trees. Biol Cybern 66:49-60 [PubMed]
Aiken CB (2007) Pramipexole in psychiatry: a systematic review of the literature. J Clin Psychiatry 68:1230-6 [PubMed]
Alt A, Weiss B, Ogden AM, Li X, Gleason SD, Calligaro DO, Bleakman D, Witkin JM (2006) In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders. Psychopharmacology (Berl) 185:240-7 [Journal] [PubMed]
Amano T, Aihua Z, Matsubayashi H, Seki T, Serikawa T, Sasa M, Sakai N (2004) Antiepileptic effects of single and repeated oral administrations of S-312-d, a novel calcium channel antagonist, on tonic convulsions in spontaneously epileptic rats. J Pharmacol Sci 95:355-62 [PubMed]
Amico C, Marchetti C, Nobile M, Usai C (1995) Pharmacological types of calcium channels and their modulation by baclofen in cerebellar granules. J Neurosci 15:2839-48 [PubMed]
Anis N, Sherby S, Goodnow R, Niwa M, Konno K, Kallimopoulos T, Bukownik R, Nakanishi K, Usherwood P, Eldefrawi A (1990) Structure-activity relationships of philanthotoxin analogs and polyamines on N-methyl-D-aspartate and nicotinic acetylcholine receptors. J Pharmacol Exp Ther 254:764-73 [PubMed]
Annoura H, Nakanishi K, Toba T, Takemoto N, Imajo S, Miyajima A, Tamura-Horikawa Y, Tamura S (2000) Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity. J Med Chem 43:3372-6 [PubMed]
Aradi I, Erdi P (2006) Computational neuropharmacology: dynamical approaches in drug discovery. Trends Pharmacol Sci 27:240-3 [Journal] [PubMed]
Ascoli GA (2006) Mobilizing the base of neuroscience data: the case of neuronal morphologies. Nat Rev Neurosci 7:318-24 [Journal] [PubMed]
Ascoli GA, Donohue DE, Halavi M (2007) NeuroMorpho.Org: a central resource for neuronal morphologies. J Neurosci 27:9247-51 [Journal] [PubMed]
Audic-Gerard F, Szepetowski P, Genton P (2003) [GEFS + syndrome: phenotypic variations from the newborn to the adult in a large French pedigree] Rev Neurol (Paris) 159:189-95
Baf MH, Subhash MN, Lakshmana KM, Rao BS (1994) Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem Int 24:67-72 [PubMed]
Bai O, Zhang H, Li XM (2004) Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res 1010:81-6 [Journal] [PubMed]
Bauer J, Schwalen S (2000) [Topiramate (Topamax). Pharmacological characteristics and current use in epilepsy treatment] Nervenarzt 71:495-501
Bayes M, Rabasseda X, Prous JR (2007) Gateways to clinical trials. Methods Find Exp Clin Pharmacol 29:625-55
Bell DC, Butcher AJ, Berrow NS, Page KM, Brust PF, Nesterova A, Stauderman KA, Seabrook GR, Nürnberg B, Dolphin AC (2001) Biophysical properties, pharmacology, and modulation of human, neuronal L-type (alpha(1D), Ca(V)1.3) voltage-dependent calcium currents. J Neurophysiol 85:816-27 [Journal] [PubMed]
Béracochéa D, Philippin JN, Meunier S, Morain P, Bernard K (2007) Improvement of episodic contextual memory by S 18986 in middle-aged mice: comparison with donepezil. Psychopharmacology (Berl) 193:63-73 [Journal] [PubMed]
Berger ML, Rebernik P (1999) Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex. J Pharmacol Exp Ther 289:1584-91 [PubMed]
Bezprozvanny I, Bezprozvannaya S, Ehrlich BE (1994) Caffeine-induced inhibition of inositol(1,4,5)-trisphosphate-gated calcium channels from cerebellum. Mol Biol Cell 5:97-103 [PubMed]
Bhalla US, Iyengar R (1999) Emergent properties of networks of biological signaling pathways. Science 283:381-7 [PubMed]
   Emergent properties of networks of biological signaling pathways (Bhalla, Iyengar 1999) [Model]
Black KJ, Hershey T, Koller JM, Videen TO, Mintun MA, Price JL, Perlmutter JS (2002) A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc Natl Acad Sci U S A 99:17113-8 [Journal] [PubMed]
Bogan RK (2008) Ropinirole treatment for restless legs syndrome. Expert Opin Pharmacother 9:611-23 [Journal] [PubMed]
Boulenger JP, Marangos PJ (1989) Caffeine withdrawal affects central adenosine receptors but not benzodiazepine receptors. J Neural Transm Gen Sect 78:9-15
Bourasset F, Bernard K, Muñoz C, Genissel P, Scherrmann JM (2005) Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat. Drug Metab Dispos 33:1137-43 [Journal] [PubMed]
Bower JM, Beeman D (1995) The Book of GENESIS: Exploring Realistic Neural Models with the GEneral NEural SImulation System. [Journal]
Brier TJ, Mellor IR, Tikhonov DB, Neagoe I, Shao Z, Brierley MJ, Strømgaard K, Jaroszewski JW, Krogsgaard-Larsen P, Usherwood PN (2003) Contrasting actions of philanthotoxin-343 and philanthotoxin-(12) on human muscle nicotinic acetylcholine receptors. Mol Pharmacol 64:954-64 [Journal] [PubMed]
Buckner SA, Milicic I, Daza A, Davis-Taber R, Scott VE, Sullivan JP, Brioni JD (2000) Pharmacological and molecular analysis of ATP-sensitive K(+) channels in the pig and human detrusor. Eur J Pharmacol 400:287-95 [PubMed]
Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, Biederman J (2008) Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry 65:102-14 [Journal] [PubMed]
Calfa G, Bussolino D, Molina VA (2007) Involvement of the lateral septum and the ventral Hippocampus in the emotional sequelae induced by social defeat: role of glucocorticoid receptors. Behav Brain Res 181:23-34 [Journal] [PubMed]
Callaway JK, Castillo-Melendez M, Giardina SF, Krstew EK, Beart PM, Jarrott B (2004) Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence. Neuropharmacology 47:146-55 [Journal] [PubMed]
Callaway JK, Knight MJ, Watkins DJ, Beart PM, Jarrott B (1999) Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke 30:2704-12; discussion 2712 [PubMed]
Camerino DC, Tricarico D, Desaphy JF (2007) Ion channel pharmacology. Neurotherapeutics 4:184-98 [Journal] [PubMed]
Carter AJ, Grauert M, Pschorn U, Bechtel WD, Bartmann-Lindholm C, Qu Y, Scheuer T, Catterall WA, Weiser T (2000) Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL. Proc Natl Acad Sci U S A 97:4944-9 [Journal] [PubMed]
Castelli L, Magistretti J (2006) High-voltage-activated Ca2+ currents show similar patterns of expression in stellate and pyramidal cells from rat entorhinal cortex layer II. Brain Res 1090:76-88 [Journal] [PubMed]
Chapman DE, Keefe KA, Wilcox KS (2003) Evidence for functionally distinct synaptic NMDA receptors in ventromedial versus dorsolateral striatum. J Neurophysiol 89:69-80 [Journal] [PubMed]
Chazot PL (2001) Safinamide (Newron Pharmaceuticals). Curr Opin Investig Drugs 2:809-13 [PubMed]
Cheney JA, Weisser JD, Bareyre FM, Laurer HL, Saatman KE, Raghupathi R, Gribkoff V, Starrett JE, McIntosh TK (2001) The maxi-K channel opener BMS-204352 attenuates regional cerebral edema and neurologic motor impairment after experimental brain injury. J Cereb Blood Flow Metab 21:396-403 [Journal] [PubMed]
Chorvat RJ, Zaczek R, Brown BS (1998) Ion channel modulators that enhance acetylcholine release: potential therapies for Alzheimer's disease. Expert Opin Investig Drugs 7:499-518 [Journal] [PubMed]
Chung JM, Huguenard JR, Prince DA (1993) Transient enhancement of low-threshold calcium current in thalamic relay neurons after corticectomy. J Neurophysiol 70:20-7 [Journal] [PubMed]
Cohen SP, Dragovich A (2007) Intrathecal analgesia. Anesthesiol Clin 25:863-82, viii [Journal] [PubMed]
Contreras M, Ceric F, Torrealba F (2007) Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium. Science 318:655-8 [Journal] [PubMed]
Coppola G, Capovilla G, Montagnini A, Romeo A, Spanò M, Tortorella G, Veggiotti P, Viri M, Pascotto A (2002) Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 49:45-8 [PubMed]
Cui G, Bernier BE, Harnett MT, Morikawa H (2007) Differential regulation of action potential- and metabotropic glutamate receptor-induced Ca2+ signals by inositol 1,4,5-trisphosphate in dopaminergic neurons. J Neurosci 27:4776-85 [Journal] [PubMed]
Cunningham MO, Woodhall GL, Thompson SE, Dooley DJ, Jones RS (2004) Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur J Neurosci 20:1566-76 [Journal] [PubMed]
D'Angelo E, Nieus T, Maffei A, Armano S, Rossi P, Taglietti V, Fontana A, Naldi G (2001) Theta-frequency bursting and resonance in cerebellar granule cells: experimental evidence and modeling of a slow k+-dependent mechanism. J Neurosci 21:759-70 [PubMed]
   Bursting and resonance in cerebellar granule cells (D'Angelo et al. 2001) [Model]
Dan Y, Poo MM (2006) Spike timing-dependent plasticity: from synapse to perception. Physiol Rev 86:1033-48 [Journal] [PubMed]
Danysz W, Parsons CG (2002) Neuroprotective potential of ionotropic glutamate receptor antagonists. Neurotox Res 4:119-26 [Journal] [PubMed]
Dave JR, Lin Y, Ved HS, Koenig ML, Clapp L, Hunter J, Tortella FC (2001) RS-100642-198, a novel sodium channel blocker, provides differential neuroprotection against hypoxia/hypoglycemia, veratridine or glutamate-mediated neurotoxicity in primary cultures of rat cerebellar neurons. Neurotox Res 3:381-95 [PubMed]
Dave JR, Yao C, Moffett JR, Berti R, Koenig M, Tortella FC (2003) Down regulation of sodium channel Na(v)1.1 expression by veratridine and its reversal by a novel sodium channel blocker, RS100642, in primary neuronal cultures. Neurotox Res 5:213-20 [PubMed]
de Paulis T (2007) Drug evaluation: Vilazodone--a combined SSRI and 5-HT1A partial agonist for the treatment of depression. IDrugs 10:193-201 [PubMed]
Dekker LV, Daniels Z, Hick C, Elsegood K, Bowden S, Szestak T, Burley JR, Southan A, Cronk D, James IF (2005) Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells. Eur J Pharmacol 528:52-8 [Journal] [PubMed]
Denes L, Szilágyi G, Gál A, Nagy Z (2006) Talampanel a non-competitive AMPA-antagonist attenuates caspase-3 dependent apoptosis in mouse brain after transient focal cerebral ischemia. Brain Res Bull 70:260-2 [Journal] [PubMed]
Di Donato M, Maioli M, Venturi F, Bürgisser C, Fantini F, Biamino G, Marchionni N (1991) Acute hemodynamic effects of intravenous diperdipine, a new dihydropyridine derivative, in coronary heart disease. Am Heart J 121:776-81 [PubMed]
Dodt HU, Leischner U, Schierloh A, Jährling N, Mauch CP, Deininger K, Deussing JM, Eder M, Zieglgänsberger W, Becker K (2007) Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brain. Nat Methods 4:331-6 [Journal] [PubMed]
Du F, Li R, Huang Y, Li X, Le W (2005) Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons. Eur J Neurosci 22:2422-30 [Journal] [PubMed]
Easton N, Marshall F, Fone K, Marsden C (2007) Atomoxetine produces changes in cortico-basal thalamic loop circuits: assessed by phMRI BOLD contrast. Neuropharmacology 52:812-26 [Journal] [PubMed]
Eghbali M, Curmi JP, Birnir B, Gage PW (1997) Hippocampal GABA(A) channel conductance increased by diazepam. Nature 388:71-5 [Journal] [PubMed]
Egorov AV, Heinemann U, Müller W (2002) Differential excitability and voltage-dependent Ca2+ signalling in two types of medial entorhinal cortex layer V neurons. Eur J Neurosci 16:1305-12 [PubMed]
Eigyo M, Shiomi T, Inoue Y, Sakaguchi I, Ishibashi C, Murata S, Koyabu K, Matsushita A, Adachi I, Ueda M (1994) Pharmacological studies on a new dihydrothienopyridine calcium antagonist, S-312-d. 5th communication: anticonvulsant effects in mice. Jpn J Pharmacol 65:175-7 [PubMed]
Elefsinioti AL, Bagos PG, Spyropoulos IC, Hamodrakas SJ (2004) A database for G proteins and their interaction with GPCRs. BMC Bioinformatics 5:208 [Journal] [PubMed]
Fernandez HH, Chen JJ (2007) Monoamine oxidase-B inhibition in the treatment of Parkinson's disease. Pharmacotherapy 27:174S-185S [Journal] [PubMed]
Fischer F, Matthisson M, Herrling P (2004) List of drugs in development for neurodegenerative diseases. Neurodegener Dis 1:50-70
Foster JD, Cervinski MA, Gorentla BK, Vaughan RA (2006) Regulation of the dopamine transporter by phosphorylation. Handb Exp Pharmacol 64:197-214
Fujiki M, Kobayashi H, Uchida S, Inoue R, Ishii K (2005) Neuroprotective effect of donepezil, a nicotinic acetylcholine-receptor activator, on cerebral infarction in rats. Brain Res 1043:236-41 [Journal] [PubMed]
Gardner D, Shepherd GM (2004) A gateway to the future of neuroinformatics. Neuroinformatics 2:271-4 [Journal] [PubMed]
Gaster LM, King FD (1997) Serotonin 5-HT3 and 5-HT4 receptor antagonists. Med Res Rev 17:163-214 [PubMed]
Gauthier S, Leblanc R, Robitaille Y, Quirion R, Carlsson G, Beaulieu M, Bouchard R, Dastoor D, Ervin F, Gauthier L (1986) Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonists. Can J Neurol Sci 13:394-402 [PubMed]
Gazulla J, Tintore MA (2007) The P/Q-type voltage-dependent calcium channel as pharmacological target in spinocerebellar ataxia type 6: gabapentin and pregabalin may be of therapeutic benefit. Med Hypotheses 68:131-6
Gefvert O, Lundberg T, Wieselgren IM, Bergström M, Långström B, Wiesel F, Lindström L (2001) D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. Eur Neuropsychopharmacol 11:105-10 [PubMed]
Gernert M, Fedrowitz M, Wlaz P, Löscher W (2004) Subregional changes in discharge rate, pattern, and drug sensitivity of putative GABAergic nigral neurons in the kindling model of epilepsy. Eur J Neurosci 20:2377-86 [Journal] [PubMed]
Giardina WJ, Williams M (2001) Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data. CNS Drug Rev 7:305-16 [PubMed]
Giovannini F, Sher E, Webster R, Boot J, Lang B (2002) Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions. Br J Pharmacol 136:1135-45 [Journal] [PubMed]
Goldstein J, Silberstein SD, Saper JR, Ryan RE, Lipton RB (2006) Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache 46:444-53 [Journal] [PubMed]
Gopalakrishnan M, Whiteaker KL, Molinari EJ, Davis-Taber R, Scott VE, Shieh CC, Buckner SA, Milicic I, Cain JC, Postl S, Sullivan JP, Brioni JD (1999) Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cells. J Pharmacol Exp Ther 289:551-8 [PubMed]
Gorelick DA, Gardner EL, Xi ZX (2004) Agents in development for the management of cocaine abuse. Drugs 64:1547-73 [Journal] [PubMed]
Gören MZ, Onat F (2007) Ethosuximide: from bench to bedside. CNS Drug Rev 13:224-39 [Journal] [PubMed]
Gourion D, Perrin E, Quintin P (2006) [Fluoxetine: an update of its use in major depressive disorder in adults] Encephale 30:392-9
Green W, Patil P, Marsden CA, Bennett GW, Wigmore PM (2006) Treatment with olanzapine increases cell proliferation in the subventricular zone and prefrontal cortex. Brain Res 1070:242-5 [Journal] [PubMed]
Hall ED, Andrus PK, Oostveen JA, Althaus JS, VonVoigtlander PF (1996) Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons. Brain Res 742:80-8 [PubMed]
Happe S, Sauter C, Klösch G, Saletu B, Zeitlhofer J (2003) Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 48:82-6 [Journal] [PubMed]
Hasselmo ME (1995) Neuromodulation and cortical function: modeling the physiological basis of behavior. Behav Brain Res 67:1-27 [PubMed]
Heidbreder C (2005) Novel pharmacotherapeutic targets for the management of drug addiction. Eur J Pharmacol 526:101-12 [Journal] [PubMed]
Hewawasam P, Erway M, Moon SL, Knipe J, Weiner H, Boissard CG, Post-Munson DJ, Gao Q, Huang S, Gribkoff VK, Meanwell NA (2002) Synthesis and structure-activity relationships of 3-aryloxindoles: a new class of calcium-dependent, large conductance potassium (maxi-K) channel openers with neuroprotective properties. J Med Chem 45:1487-99 [PubMed]
Hewawasam P, Gribkoff VK, Pendri Y, Dworetzky SI, Meanwell NA, Martinez E, Boissard CG, Post-Munson DJ, Trojnacki JT, Yeleswaram K, Pajor LM, Knipe J, Gao Q, Perrone R, Starrett JE (2002) The synthesis and characterization of BMS-204352 (MaxiPost) and related 3-fluorooxindoles as openers of maxi-K potassium channels. Bioorg Med Chem Lett 12:1023-6 [PubMed]
Hines ML, Carnevale NT (1997) The NEURON simulation environment. Neural Comput 9:1179-209 [PubMed]
Howes JF, Bell C (2007) Talampanel. Neurotherapeutics 4:126-9 [Journal] [PubMed]
Hoyte L, Barber PA, Buchan AM, Hill MD (2004) The rise and fall of NMDA antagonists for ischemic stroke. Curr Mol Med 4:131-6 [PubMed]
http, ()
http, ()
http, ()
http, ()
http, ()
http, ()
http, ()
http, ()
Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA (2005) Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone. Eur J Pharmacol 510:49-57 [Journal] [PubMed]
Huguenard JR (1996) Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol 58:329-48 [Journal] [PubMed]
Hunnicutt EJ, Davis JN, Chisholm JC (1994) A new glibenclamide-insensitive neuroselective hyperpolarizing agent. Eur J Pharmacol 261:R1-3 [PubMed]
Iivanainen M (1998) Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability. J Intellect Disabil Res 42 Suppl 1:24-31 [PubMed]
Iwama T, Nagai Y, Tamura N, Harada S, Nagaoka A (1991) A novel glutamate agonist, TAN-950 A, isolated from streptomycetes. Eur J Pharmacol 197:187-92 [PubMed]
Jakus R, Graf M, Ando RD, Balogh B, Gacsalyi I, Levay G, Kantor S, Bagdy G (2004) Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res 1008:236-44 [Journal] [PubMed]
Jansen JF, Aldenkamp AP, Marian Majoie HJ, Reijs RP, de Krom MC, Hofman PA, Eline Kooi M, Nicolay K, Backes WH (2006) Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy. Epilepsy Behav 9:181-5 [Journal] [PubMed]
Jensen BS (2002) BMS-204352: a potassium channel opener developed for the treatment of stroke. CNS Drug Rev 8:353-60 [PubMed]
Jones N, O'Neill MJ, Tricklebank M, Libri V, Williams SC (2005) Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) 180:743-51 [Journal] [PubMed]
Juckel G, Schlagenhauf F, Koslowski M, Wustenberg T, Villringer A, Knutson B, Wrase J, Heinz (2006) Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 29:409-16
Kasim S, Blake BL, Fan X, Chartoff E, Egami K, Breese GR, Hess EJ, Jinnah HA (2006) The role of dopamine receptors in the neurobehavioral syndrome provoked by activation of L-type calcium channels in rodents. Dev Neurosci 28:505-17 [Journal] [PubMed]
Katz I, Kim J, Gale K, Kondratyev A (2007) Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther 322:494-500 [Journal] [PubMed]
Kendall TJ, Minchin MC (1982) The effects of anaesthetics on the uptake and release of amino acid neurotransmitters in thalamic slices. Br J Pharmacol 75:219-27 [PubMed]
Kiss T, Erdi P (2006) From electric patterns to drugs: perspectives of computational neuroscience in drug design. Biosystems 86:46-52 [Journal] [PubMed]
Kondashevskaya MV, Kudrin VS, Malikova LA, Klodt PM, Makarova OV (2006) Effect of single and repeated administration of high-molecular-weight heparin in low doses on brain content of neurotransmitters in Wistar rats. Bull Exp Biol Med 141:599-601 [PubMed]
Korngreen A, Kaiser KM, Zilberter Y (2005) Subthreshold inactivation of voltage-gated K+ channels modulates action potentials in neocortical bitufted interneurones from rats. J Physiol 562:421-37 [Journal] [PubMed]
   Subthreshold inact. of K channels modulates APs in bitufted interneurons (Korngreen et al 2005) [Model]
Korsgaard MP, Hartz BP, Brown WD, Ahring PK, Strøbaek D, Mirza NR (2005) Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. J Pharmacol Exp Ther 314:282-92 [Journal] [PubMed]
Kotaleski JH, Lester D, Blackwell KT (2002) Subcellular interactions between parallel fibre and climbing fibre signals in Purkinje cells predict sensitivity of classical conditioning to interstimulus interval. Integr Physiol Behav Sci 37:265-92 [PubMed]
Kotani Y, Morimoto N, Oida Y, Tamura Y, Tamura S, Inoue T, Shimazawa M, Yoshimura S, Iwama T, (2007) Prevention of in vitro and in vivo acute ischemic neuronal damage by (2S)-1-(4-amino-2,3,5-trimethylphenoxy)-3-{4-[4-(4-fluorobenzyl) phenyl]-1-piperazinyl}-2-propanol dimethanesulfonate (SUN N8075), a novel neuroprotective agent with antioxidant properties. Neuroscience 149:779-88
Kroppenstedt SN, Schneider GH, Thomale UW, Unterberg AW (1998) Neuroprotective properties of aptiganel HCL (Cerestat) following controlled cortical impact injury. Acta Neurochir Suppl 71:114-6 [PubMed]
Kwon MO, Fischer F, Matthisson M, Herrling P (2004) List of drugs in development for neurodegenerative diseases. Update June 2004. Neurodegener Dis 1:113-52 [Journal] [PubMed]
Kwon MO, Herrling P (2006) List of drugs in development for neurodegenerative diseases. Update June 2006. Neurodegener Dis 3:148-86 [Journal] [PubMed]
Lazareno S, Popham A, Birdsall NJ (2003) Progress toward a high-affinity allosteric enhancer at muscarinic M1 receptors. J Mol Neurosci 20:363-7 [Journal] [PubMed]
Lea PM, Faden AI (2006) Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev 12:149-66 [Journal] [PubMed]
Lee CR, Tepper JM (2007) A calcium-activated nonselective cation conductance underlies the plateau potential in rat substantia nigra GABAergic neurons. J Neurosci 27:6531-41 [Journal] [PubMed]
Lee CY, Fu WM, Chen CC, Su MJ, Liou HH (2008) Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia 49:888-97 [Journal] [PubMed]
Lee HJ, Pogatzki-Zahn EM, Brennan TJ (2006) The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain. J Pain 7:768-77 [Journal] [PubMed]
Levin ED, McClernon FJ, Rezvani AH (2006) Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184:523-39 [Journal] [PubMed]
Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY (2005) ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Psychopharmacology (Berl) 183:144-53 [Journal] [PubMed]
Lindskog M, Kim M, Wikström MA, Blackwell KT, Kotaleski JH (2006) Transient calcium and dopamine increase PKA activity and DARPP-32 phosphorylation. PLoS Comput Biol 2:e119 [Journal] [PubMed]
   Model of DARPP-32 phosphorylation in striatal medium spiny neurons (Lindskog et al. 2006) [Model]
Lockhart BP, Rodriguez M, Mourlevat S, Peron P, Catesson S, Villain N, Galizzi JP, Boutin JA, Lestage P (2007) S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures. Eur J Pharmacol 561:23-31 [Journal] [PubMed]
Maguire GA (2002) Comprehensive understanding of schizophrenia and its treatment. Am J Health Syst Pharm 59:S4-11 [Journal] [PubMed]
Malphrus AD, Wilfong AA (2007) Use of the newer antiepileptic drugs in pediatric epilepsies. Curr Treat Options Neurol 9:256-67 [PubMed]
Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S (2007) Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry 164:1411-7 [Journal] [PubMed]
Markram H (2006) The blue brain project. Nat Rev Neurosci 7:153-60 [Journal] [PubMed]
Marzatico F, Dagani F, Curti D, Benzi G (1987) Phenobarbital and 6-aminonicotinamide effect on cerebral enzymatic activities related to energy metabolism in different rat brain areas. Neurochem Res 12:33-9 [PubMed]
McLeod MC, Sundram S, Dean B (2008) Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 32:560-7 [Journal] [PubMed]
Menon M, Jensen J, Vitcu I, Graff-Guerrero A, Crawley A, Smith MA, Kapur S (2007) Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation. Biol Psychiatry 62:765-72 [Journal] [PubMed]
Meshkibaf MH, Subhash MN, Lakshmana KM, Rao BS (1995) Effect of chronic administration of phenytoin on regional monoamine levels in rat brain. Neurochem Res 20:773-8 [PubMed]
Meyer JH, Goulding VS, Wilson AA, Hussey D, Christensen BK, Houle S (2002) Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology (Berl) 163:102-5 [Journal] [PubMed]
Meythaler J (2002) BIII-890-CL. Boehringer Ingelheim. Curr Opin Investig Drugs 3:1733-5 [PubMed]
Micheva KD, Taylor CP, Smith SJ (2006) Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol Pharmacol 70:467-76 [Journal] [PubMed]
Migliore M, Cannia C, Canavier CC (2008) A modeling study suggesting a possible pharmacological target to mitigate the effects of ethanol on reward-related dopaminergic signaling. J Neurophysiol 99:2703-7 [Journal] [PubMed]
   Nigral dopaminergic neurons: effects of ethanol on Ih (Migliore et al. 2008) [Model]
Migliore M, Messineo L, Ferrante M (2004) Dendritic Ih selectively blocks temporal summation of unsynchronized distal inputs in CA1 pyramidal neurons. J Comput Neurosci 16:5-13 [PubMed]
   CA1 pyramidal neuron: effects of Ih on distal inputs (Migliore et al 2004) [Model]
Migliore M, Morse TM, Davison AP, Marenco L, Shepherd GM, Hines ML (2003) ModelDB: making models publicly accessible to support computational neuroscience. Neuroinformatics 1:135-9 [Journal] [PubMed]
Migliore M, Shepherd GM (2002) Emerging rules for the distributions of active dendritic conductances. Nat Rev Neurosci 3:362-70 [Journal] [PubMed]
   Modulation of temporal integration window (Migliore, Shepherd 2002) [Model]
Mikami A, Masuoka T, Yasuda M, Yamamoto Y, Kamei C (2007) Participation of cholinergic system in memory deficits induced by blockade of hippocampal mGlu(1) receptors. Eur J Pharmacol 575:82-6 [Journal] [PubMed]
Møller A, Christophersen P, Drejer J, Axelsson O, Peters D, Jensen LH, Nielsen EO (1995) Pharmacological profile and anti-ischemic properties of the Ca(2+)-channel blocker NS-638. Neurol Res 17:353-60 [PubMed]
Montgomery SA, Baldwin DS, Blier P, Fineberg NA, Kasper S, Lader M, Lam RW, Lepine JP, Moller (2007) Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol 22:323-9
Mora TC, Suarez-Kurtz G (2005) Effects of NS1608, a BK(Ca) channel agonist, on the contractility of guinea-pig urinary bladder in vitro. Br J Pharmacol 144:636-41 [Journal] [PubMed]
Muir KW, Grosset DG, Lees KR (1997) Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers. Clin Neuropharmacol 20:311-21
Mutani R, Cantello R, Gianelli M, Civardi C (1995) Antiepileptic drugs and mechanisms of epileptogenesis. A review. Ital J Neurol Sci 16:217-22 [PubMed]
Nasledov GA, Skvortsova IV, Skorobovichuk NF (2007) [Effect of inositol triphosphate receptor blocker heparin on contractions in the Lampetra fluviatilis muscle] Zh Evol Biokhim Fiziol 37:74-6
Nicolazzo JA, Nguyen TT, Katneni K, Steuten JA, Smith G, Jarrott B, Callaway JK, Charman SA (2008) Pharmacokinetics and brain uptake of AM-36, a novel neuroprotective agent, following intravenous administration to rats. J Pharm Pharmacol 60:171-8 [Journal] [PubMed]
Nordquist RE, Steckler T, Wettstein JG, Mackie C, Spooren W (2008) Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety. Psychopharmacology (Berl) 199:389-402 [Journal] [PubMed]
O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I (2007) Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology (Berl) 192:357-71 [Journal] [PubMed]
O'Neill MJ, Bath CP, Dell CP, Hicks CA, Gilmore J, Ambler SJ, Ward MA, Bleakman D (1997) Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo. Eur J Pharmacol 332:121-31 [PubMed]
Obrietan K, van den Pol AN (1999) GABAB receptor-mediated regulation of glutamate-activated calcium transients in hypothalamic and cortical neuron development. J Neurophysiol 82:94-102 [Journal] [PubMed]
Olesen SP, Møller A, Mordvintcev PI, Busse R, Mülsch A (1997) Regional measurements of NO formed in vivo during brain ischemia. Acta Neurol Scand 95:219-24 [PubMed]
Paloyelis Y, Mehta MA, Kuntsi J, Asherson P (2007) Functional MRI in ADHD: a systematic literature review. Expert Rev Neurother 7:1337-56 [Journal] [PubMed]
Parihar AS, Groebe DR, Scott VE, Feng J, Zhang XF, Warrior U, Gopalakrishnan M, Shieh CC (2003) Functional analysis of large conductance Ca2(+)-activated K(+) channels: ion flux studies by atomic absorption spectrometry. Assay Drug Dev Technol 1:647-54 [Journal] [PubMed]
Pattij T, Vanderschuren LJ (2008) The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29:192-9 [Journal] [PubMed]
Petroff OA, Hyder F, Rothman DL, Mattson RH (2001) Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 42:543-8 [PubMed]
Poolos NP, Migliore M, Johnston D (2002) Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites. Nat Neurosci 5:767-74 [Journal] [PubMed]
   CA1 pyramidal neuron: effects of Lamotrigine on dendritic excitability (Poolos et al 2002) [Model]
Popescu BO, Oprica M, Sajin M, Stanciu CL, Bajenaru O, Predescu A, Vidulescu C, Popescu LM (2006) Dantrolene protects neurons against kainic acid induced apoptosis in vitro and in vivo. J Cell Mol Med 6:555-69
Posner EB, Mohamed K, Marson AG (2005) A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine. Seizure 14:117-22
Quiroz JA, Gould TD, Manji HK (2004) Molecular effects of lithium. Mol Interv 4:259-72 [Journal] [PubMed]
Ramaprasad S, Ripp E, Pi J, Lyon M (2005) Pharmacokinetics of lithium in rat brain regions by spectroscopic imaging. Magn Reson Imaging 23:859-63 [Journal] [PubMed]
Ramirez AD, Wong SK, Menniti FS (2003) Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms. Eur J Pharmacol 475:29-35 [PubMed]
Reimann W, Schneider F (1998) Induction of 5-hydroxytryptamine release by tramadol, fenfluramine and reserpine. Eur J Pharmacol 349:199-203 [PubMed]
Reneman L, De Bruin K, Lavalaye J, Gunning WB, Booij J (2001) Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus. Synapse 39:193-200 [Journal] [PubMed]
Reymann K, Pohle W, Müller-Welde P, Ott T (1983) Dopaminergic innervation of the hippocampus: evidence for midbrain raphe neurons as the site of origin. Biomed Biochim Acta 42:1247-55 [PubMed]
Reynolds GP, Mason SL, Meldrum A, De Keczer S, Parnes H, Eglen RM, Wong EH (1995) 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br J Pharmacol 114:993-8 [PubMed]
Reynolds MF, Sisk EC, Rasgon NL (2007) Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review. Curr Med Chem 14:2799-812 [PubMed]
Rogawski MA (2006) Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 69:273-94 [Journal] [PubMed]
Rose GM, Ong VS, Woodruff-Pak DS (2007) Efficacy of MEM 1003, a novel calcium channel blocker, in delay and trace eyeblink conditioning in older rabbits. Neurobiol Aging 28:766-73 [Journal] [PubMed]
Rose JE, Behm FM, Salley AN, Bates JE, Coleman RE, Hawk TC, Turkington TG (2007) Regional brain activity correlates of nicotine dependence. Neuropsychopharmacology 32:2441-52 [Journal] [PubMed]
Rosenberg H, Davis M, James D, Pollock N, Stowell K (2007) Malignant hyperthermia. Orphanet J Rare Dis 2:21 [Journal] [PubMed]
Rosi S, Giovannini MG, Lestage PJ, Munoz C, Corte LD, Pepeu G (2004) S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat. Neurosci Lett 361:120-3
Sandrini G, Perrotta A, Nappi G (2006) Eletriptan: a review and new perspectives. Expert Rev Neurother 6:1413-21 [Journal] [PubMed]
Sansone V, Tawil R (2007) Management and treatment of Andersen-Tawil syndrome (ATS). Neurotherapeutics 4:233-7 [Journal] [PubMed]
Saraga F, Wu CP, Zhang L, Skinner FK (2003) Active dendrites and spike propagation in multi-compartment models of oriens-lacunosum/moleculare hippocampal interneurons. J Physiol 552:673-89 [Journal] [PubMed]
   Active dendrites and spike propagation in a hippocampal interneuron (Saraga et al 2003) [Model]
Schiffer WK, Volkow ND, Fowler JS, Alexoff DL, Logan J, Dewey SL (2006) Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse 59:243-51 [Journal] [PubMed]
Schoepp DD, Wright RA, Levine LR, Gaydos B, Potter WZ (2003) LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress. Stress 6:189-97 [Journal] [PubMed]
Schrøder RL, Jespersen T, Christophersen P, Strøbaek D, Jensen BS, Olesen SP (2001) KCNQ4 channel activation by BMS-204352 and retigabine. Neuropharmacology 40:888-98 [PubMed]
Schüle C (2007) Neuroendocrinological mechanisms of actions of antidepressant drugs. J Neuroendocrinol 19:213-26 [Journal] [PubMed]
Schwarz AJ, Gozzi A, Reese T, Bifone A (2007) In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI. Neuroimage 34:1627-36 [Journal] [PubMed]
Schwarz AJ, Gozzi A, Reese T, Heidbreder CA, Bifone A (2007) Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A. Magn Reson Imaging 25:811-20 [Journal] [PubMed]
Shan H, Messi ML, Zheng Z, Wang ZM, Delbono O (2003) Preservation of motor neuron Ca2+ channel sensitivity to insulin-like growth factor-1 in brain motor cortex from senescent rat. J Physiol 553:49-63 [Journal] [PubMed]
Shapiro RE (2007) Caffeine and headaches. Neurol Sci 28 Suppl 2:S179-83 [Journal] [PubMed]
Shieh CC, Turner SC, Zhang XF, Milicic I, Parihar A, Jinkerson T, Wilkins J, Buckner SA, Gopalakrishnan M (2007) A-272651, a nonpeptidic blocker of large-conductance Ca2+-activated K+ channels, modulates bladder smooth muscle contractility and neuronal action potentials. Br J Pharmacol 151:798-806 [Journal] [PubMed]
Siddiqui A, Niazi A, Shaharyar S, Wilson CA (2007) The 5HT(7) receptor subtype is involved in the regulation of female sexual behaviour in the rat. Pharmacol Biochem Behav 87:386-92 [Journal] [PubMed]
Silberstein SD, Cady RK, Sheftell FD, Almas M, Parsons B, Albert KS (2007) Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes. Headache 47:673-82 [Journal] [PubMed]
Simonyi A, Schachtman TR, Christoffersen GR (2007) The role of metabotropic glutamate receptor 5 in learning and memory processes. Drug News Perspect 18:353-61
Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS (2003) Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor. Eur J Pharmacol 461:99-104 [PubMed]
Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS (2003) "Broad spectrum" antidepressants: is more better for the treatment of depression? Life Sci 73:3175-9 [PubMed]
Slassi A, Isaac M, Edwards L, Minidis A, Wensbo D, Mattsson J, Nilsson K, Raboisson P, McLeod D, Stormann TM, Hammerland LG, Johnson E (2005) Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications. Curr Top Med Chem 5:897-911 [PubMed]
Slattery DA, Morrow JA, Hudson AL, Hill DR, Nutt DJ, Henry B (2005) Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compounds. Neuropsychopharmacology 30:1278-87 [Journal] [PubMed]
Smith CP, Woods-Kettelberger AT, Corbett R, Chesson SM, Bores GM, Petko WW, Roehr JE, Kongsamut S (1996) Serotonergic activity of HP 184: does spontaneous release have a role? Neurochem Res 21:575-83 [PubMed]
Solai LK, Mulsant BH, Pollock BG (2001) Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drugs Aging 18:355-68 [Journal] [PubMed]
Soldovieri MV, Cilio MR, Miceli F, Bellini G, Miraglia del Giudice E, Castaldo P, Hernandez CC, Shapiro MS, Pascotto A, Annunziato L, Taglialatela M (2007) Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions. J Neurosci 27:4919-28 [Journal] [PubMed]
Spinelli S, Ballard T, Gatti-McArthur S, Richards GJ, Kapps M, Woltering T, Wichmann J, Stadler H, Feldon J, Pryce CR (2005) Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys. Psychopharmacology (Berl) 179:292-302 [Journal] [PubMed]
Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen NK, Busquet P, Pelster G, Singewald N (2006) Role of voltage-gated L-type Ca2+ channel isoforms for brain function. Biochem Soc Trans 34:903-9 [Journal] [PubMed]
Strupp M, Zwergal A, Brandt T (2007) Episodic ataxia type 2. Neurotherapeutics 4:267-73 [Journal] [PubMed]
Sun L, Lin SS (2000) The anticonvulsant SGB-017 (ADCI) blocks voltage-gated sodium channels in rat and human neurons: comparison with carbamazepine. Epilepsia 41:263-70 [PubMed]
Szarfman A, Tonning JM, Levine JG, Doraiswamy PM (2006) Atypical antipsychotics and pituitary tumors: a pharmacovigilance study. Pharmacotherapy 26:748-58 [Journal] [PubMed]
Tang L, Kongsamut S (1996) Frequency-dependent inhibition of neurotransmitter release by besipirdine and HP 184. Eur J Pharmacol 300:71-4 [PubMed]
Tarnawa I, Bölcskei H, Kocsis P (2007) Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases. Recent Pat CNS Drug Discov 2:57-78 [PubMed]
Teoh H, Fowler LJ, Bowery NG (1995) Effect of lamotrigine on the electrically-evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord. Neuropharmacology 34:1273-8 [PubMed]
Uruno K, O'Connor MJ, Masukawa LM (1995) Effects of bicuculline and baclofen on paired-pulse depression in the dentate gyrus of epileptic patients. Brain Res 695:163-72 [PubMed]
Vann RE, Rosecrans JA, James JR, Philibin SD, Robinson SE (2006) Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine. Brain Res 1117:18-24 [Journal] [PubMed]
Vargas ML, Abella C, Hernandez J (2001) Diazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism. Br J Pharmacol 133:1355-61 [Journal] [PubMed]
Verheij MM, Cools AR (2007) Differential contribution of storage pools to the extracellular amount of accumbal dopamine in high and low responders to novelty: effects of reserpine. J Neurochem 100:810-21 [Journal] [PubMed]
Winston JS, Strange BA, O'Doherty J, Dolan RJ (2002) Automatic and intentional brain responses during evaluation of trustworthiness of faces. Nat Neurosci 5:277-83 [Journal] [PubMed]
Wong EY, Herbert J (2005) Roles of mineralocorticoid and glucocorticoid receptors in the regulation of progenitor proliferation in the adult hippocampus. Eur J Neurosci 22:785-92 [Journal] [PubMed]
Yagami T, Ueda K, Sakaeda T, Itoh N, Sakaguchi G, Okamura N, Hori Y, Fujimoto M (2004) Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death. Biochem Pharmacol 67:1153-65 [Journal] [PubMed]
Yasui M, Kawasaki K (1994) Vulnerability of CA1 neurons in SHRSP hippocampal slices to ischemia, and its protection by Ca2+ channel blockers. Brain Res 642:146-52 [PubMed]
Youdim MB, Buccafusco JJ (2005) CNS Targets for multi-functional drugs in the treatment of Alzheimer's and Parkinson's diseases. J Neural Transm (Vienna) 112:519-37 [Journal] [PubMed]
Young BL, Cooks RG, Madden MC, Bair M, Jia J, Aubry AF, Miller SA (2007) Chiral purity assay for Flindokalner using tandem mass spectrometry: method development, validation, and benchmarking. J Pharm Biomed Anal 43:1602-8 [Journal] [PubMed]
Zaczek R, Chorvat RJ, Saye JA, Pierdomenico ME, Maciag CM, Logue AR, Fisher BN, Rominger DH, Earl RA (1998) Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine. J Pharmacol Exp Ther 285:724-30 [PubMed]
Zarate CA, Payne JL, Singh J, Quiroz JA, Luckenbaugh DA, Denicoff KD, Charney DS, Manji HK (2004) Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry 56:54-60 [Journal] [PubMed]
Zhang D, Krishna R, Wang L, Zeng J, Mitroka J, Dai R, Narasimhan N, Reeves RA, Srinivas NR, Klunk LJ (2005) Metabolism, pharmacokinetics, and protein covalent binding of radiolabeled MaxiPost (BMS-204352) in humans. Drug Metab Dispos 33:83-93 [Journal] [PubMed]
Zhang L, Andou Y, Masuda S, Mitani A, Kataoka K (1993) Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neurosci Lett 158:105-8 [PubMed]
Zhang L, Liu Y, Chen X (2005) Carbachol induces burst firing of dopamine cells in the ventral tegmental area by promoting calcium entry through L-type channels in the rat. J Physiol 568:469-81 [Journal] [PubMed]
Zhang L, Zhang Y, Wennberg R (1998) Multiple actions of methohexital on hippocampal CA1 and cortical neurons of rat brain slices. J Pharmacol Exp Ther 286:1177-82 [PubMed]
Zhang W, Zhang Y, Zheng H, Zhang C, Xiong W, Olyarchuk JG, Walker M, Xu W, Zhao M, Zhao S, Zhou Z, Wei L (2007) SynDB: a Synapse protein DataBase based on synapse ontology. Nucleic Acids Res 35:D737-41 [Journal] [PubMed]
Zhu MY, Wang WP, Bissette G (2006) Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons. Neuroscience 141:2019-27 [Journal] [PubMed]
Cavarretta F, Carnevale NT, Tegolo D, Migliore M (2014) Effects of low frequency electric fields on synaptic integration in hippocampal CA1 pyramidal neurons: implications for power line emissions. Front Cell Neurosci 8:310 [Journal] [PubMed]
   CA1 pyramidal neurons: effect of external electric field from power lines (Cavarretta et al. 2014) [Model]
Culmone V, Migliore M (2012) Progressive effect of beta amyloid peptides accumulation on CA1 pyramidal neurons: a model study suggesting possible treatments. Front Comput Neurosci 6:52 [Journal] [PubMed]
   CA1 pyramidal neurons: effects of Alzheimer (Culmone and Migliore 2012) [Model]
Ferrante M, Ascoli GA (2015) Distinct and synergistic feedforward inhibition of pyramidal cells by basket and bistratified interneurons. Front Cell Neurosci 9:439 [Journal] [PubMed]
   Feedforward inhibition in pyramidal cells (Ferrante & Ascoli 2015) [Model]
Le Franc Y, Le Masson G (2010) Multiple firing patterns in deep dorsal horn neurons of the spinal cord: computational analysis of mechanisms and functional implications. J Neurophysiol 104:1978-96 [Journal] [PubMed]
Makadia HK, Anderson WD, Fey D, Sauter T, Schwaber JS, Vadigepalli R (2015) Multiscale model of dynamic neuromodulation integrating neuropeptide-induced signaling pathway activity with membrane electrophysiology. Biophys J 108:211-23 [Journal] [PubMed]
   Model of AngII signaling and membrane electrophysiology (Makadia, Anderson, Fey et al., 2015) [Model]
Parasuram H, Nair B, D'Angelo E, Hines M, Naldi G, Diwakar S (2016) Computational Modeling of Single Neuron Extracellular Electric Potentials and Network Local Field Potentials using LFPsim. Front Comput Neurosci 10:65 [Journal] [PubMed]
   Modeling single neuron LFPs and extracellular potentials with LFPsim (Parasuram et al. 2016) [Model]
Parekh R, Ascoli GA (2013) Neuronal morphology goes digital: a research hub for cellular and system neuroscience. Neuron 77:1017-38 [Journal] [PubMed]
   Neuronal morphology goes digital ... (Parekh & Ascoli 2013) [Model]
(241 refs)